Insider Transactions in Q3 2017 at Cvs Health Corp (CVS)
Insider Transaction List (Q3 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2017
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
85,743
-71.72%
|
$7,116,669
$83.14 P/Share
|
|
Sep 18
2017
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
85,743
+41.77%
|
$2,915,262
$34.96 P/Share
|
|
Sep 15
2017
|
Helena Foulkes EVP & President-CVS Pharmacy |
SELL
Open market or private sale
|
Direct |
39,340
-46.65%
|
$3,186,540
$81.88 P/Share
|
|
Sep 15
2017
|
Helena Foulkes EVP & President-CVS Pharmacy |
BUY
Exercise of conversion of derivative security
|
Direct |
39,340
+31.81%
|
$2,124,360
$54.53 P/Share
|
|
Sep 13
2017
|
Larry J Merlo Director |
SELL
Open market or private sale
|
Direct |
241,150
-44.62%
|
$20,015,450
$83.07 P/Share
|
|
Sep 13
2017
|
Larry J Merlo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
241,150
+30.86%
|
$8,199,100
$34.96 P/Share
|
|
Sep 11
2017
|
Thomas M Moriarty EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
90,267
-60.76%
|
$7,131,093
$79.61 P/Share
|
|
Sep 11
2017
|
Thomas M Moriarty EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
90,267
+37.78%
|
$4,603,617
$51.6 P/Share
|
|
Sep 11
2017
|
David M Denton EVP and CFO |
SELL
Open market or private sale
|
Direct |
237,078
-54.64%
|
$18,729,162
$79.64 P/Share
|
|
Sep 11
2017
|
David M Denton EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
108,183
+42.86%
|
$5,841,882
$54.53 P/Share
|
|
Aug 23
2017
|
Larry J Merlo Director |
SELL
Bona fide gift
|
Direct |
14,163
-4.52%
|
$1,090,551
$77.61 P/Share
|
|
Aug 16
2017
|
Richard J Swift Director |
SELL
Open market or private sale
|
Direct |
2,500
-43.42%
|
$197,500
$79.62 P/Share
|